Biofrontera Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biofrontera Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Biofrontera Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $42.5M, a 17.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.5M +$6.36M +17.6% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $36.2M +$5.11M +16.5% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $31.1M +$6.43M +26.1% Dec 31, 2021 8-K 2023-10-03
Q4 2020 $24.6M Dec 31, 2020 10-K 2022-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.